ALLO Latest Press Releases

-- February 5, 2026 --

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences Globe Newswire 8:30 AM

-- January 12, 2026 --

The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff Globe Newswire 10:14 AM

-- January 8, 2026 --

Allogene Therapeutics Positions 2026 as a Program-Defining Year for Scalable, Real-World Allogeneic CAR T Globe Newswire 8:30 AM

-- December 15, 2025 --

Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis Globe Newswire 5:39 PM

-- November 10, 2025 --

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences Globe Newswire 8:30 AM

-- November 6, 2025 --

Allogene Therapeutics Reports Third Quarter 2025 Financial Results and Business Update Globe Newswire 4:05 PM

-- November 3, 2025 --

Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting Globe Newswire 9:04 AM

-- October 30, 2025 --

Allogene Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software